INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 41 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $815,000 | 0.0% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $815,000 | -76.0% | 1,000,000 | -75.0% | 0.00% | -66.7% |
| Q2 2021 | $3,394,000 | -53.5% | 4,000,000 | -52.9% | 0.00% | -50.0% |
| Q1 2021 | $7,299,000 | -9.0% | 8,500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $8,017,000 | 0.0% | 8,500,000 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $8,017,000 | 0.0% | 8,500,000 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $8,017,000 | +38.7% | 8,500,000 | +41.7% | 0.01% | +28.6% |
| Q1 2020 | $5,781,000 | – | 6,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|